TECHNOLOGICAL APPLICATIONS OF NEW ANTI-NEPOLASTICI (Q2031397)
Jump to navigation
Jump to search
Project Q2031397 in Italy
Language | Label | Description | Also known as |
---|---|---|---|
English | TECHNOLOGICAL APPLICATIONS OF NEW ANTI-NEPOLASTICI |
Project Q2031397 in Italy |
Statements
84,000.0 Euro
0 references
168,000.0 Euro
0 references
50.0 percent
0 references
22 July 2016
0 references
30 April 2019
0 references
UFF_EFATTURAPA
0 references
IL PROGETTO PREVEDE LO STUDIO IN VITRO SU CULTURE PRIMARIE E LINEE CELLULARI DELLA TOSSICITÃ DEI SISTEMI DI DRUG DELIVERY SVILUPPATI DA NEALYS (B1) E L'EFFICACIA DEL TARGETTING SELETTIVO. SUCCESSIVAMENTE I SISTEMI SELEZIONATI E CARICATI CON FARMACI ANTITUMORALI SARANNO TESTATI IN VITRO SU LINEE CELLULARI DI CARCINOMA OVARICO. INOLTRE, A PARTIRE DA BIOPSIE DI TUMORE OVARICO DI PAZIENTE SARANNO ALLESTITE COLTURE ORGANOTIPICHE ED ESPERIMENTI DI XENOGRAFT IN MODELLI ANIMALI PER VALIDARE LE MOLECOL (Italian)
0 references
THE PROJECT PROVIDES FOR AN IN VITRO STUDY ON PRIMARY CULTURES AND CELL LINES OF THE DRUG DELIVERY SYSTEMS DEVELOPED BY NEALYS (B1) AND THE EFFECTIVENESS OF THE SELECTIVE TARGETING SYSTEM. SUBSEQUENTLY, SYSTEMS SELECTED AND UPLOADED WITH CANCER DRUGS WILL BE TESTED IN VITRO ON OVARIAN CANCER LINES. IN ADDITION, FROM BIOPSIES OF OVARIAN CANCER, ORGANIOTIPITA CULTURES AND EXPERIMENTS OF XENMOGRAPHY WILL BE ESTABLISHED IN ANIMALS MODELS FOR THE VALIDATION OF MOLCOL. (English)
0 references
LE PROJET COMPREND L’ÉTUDE IN VITRO DES CULTURES PRIMAIRES ET DES LIGNÉES CELLULAIRES DES SYSTÈMES D’ADMINISTRATION DE MÉDICAMENTS MIS AU POINT PAR NEALYS (B1) ET L’EFFICACITÉ DU CIBLAGE SÉLECTIF. PAR LA SUITE, LES SYSTÈMES SÉLECTIONNÉS ET CHARGÉS DE MÉDICAMENTS ANTICANCÉREUX SERONT TESTÉS IN VITRO SUR DES LIGNÉES CELLULAIRES DU CANCER DE L’OVAIRE. EN OUTRE, DES CULTURES ORGANOTYPIQUES ET DES EXPÉRIENCES DE XÉNOGREFFE DANS DES MODÈLES ANIMAUX SERONT MISES EN PLACE À PARTIR DE BIOPSIES DU CANCER DE L’OVAIRE PATIENTE POUR VALIDER LES MOLÉCULES. (French)
15 December 2021
0 references
Identifiers
C92F17000310007
0 references